Sparwasser, Peter; Epple, Stefan; Thomas, Anita et al.
NEWLY ESTABLISHED APPROACH OF AN ENTIRELY RETROPERITONEAL ROBOTIC NEPHROURETERECTOMYJOURNAL OF UROLOGY. Bd. 207. H. 5. 2022 S. E807-E808
Al-Nawas, Bilal; Rehberg, Bernd
News from the Hygiene JungleMKG-CHIRURG. Bd. 15. H. 2. 2022 S. 168-168
Hoevelmeyer, Nadine; Schmidt-Supprian, Marc; Ohnmacht, Caspar
NF-kappa B in control of regulatory T cell development, identity, and functionJOURNAL OF MOLECULAR MEDICINE-JMM. Bd. 100. H. 7. 2022 S. 985-995
Poggi, G.; Wennstrom, Malin; Mueller, M. B. et al.
NG2-glia: rising stars in stress-related mental disorders?MOLECULAR PSYCHIATRY. 2022
Vesting, Anna Juliane; Jais, Alexander; Klemm, Paul et al.
NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibitionMOLECULAR METABOLISM. Bd. 66. 2022
Shitara, Kohei; Janjigian, Yelena Y.; Moehler, Markus H. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy, safety, and subgroup analyses from CheckMate 649JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 4. 2022
Lei, Ming; Janjigian, Yelena Y.; Ajani, Jaffer A. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analysesCANCER RESEARCH. Bd. 82. H. 12. 2022
Shitara, Kohei; Ajani, Jaffer A.; Moehler, Markus et al.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancerNATURE. Bd. 603. H. 7903. 2022 S. 942-+
Wein, Bastian; Zaczkiewicz, Myron; Graf, Matthias et al.
No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results Fromthe German Austrian ABSORB Registry (GABI-R)CARDIOVASCULAR REVASCULARIZATION MEDICINE. Bd. 40. 2022 S. 144-149
de Boni, L; Odainic, A; Gancarczyk, N et al.
No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headacheNeurol Res Pract. Bd. 4. H. 1. 2022 S. 53